Aradhana M Venkatesan

Summary

Affiliation: National Institutes of Health
Country: USA

Publications

  1. ncbi Comparison of clinical and imaging features in succinate dehydrogenase-positive versus sporadic paragangliomas
    Aradhana M Venkatesan
    Center for Interventional Oncology, Radiology and Imaging Sciences, National Institutes of Health, Bethesda, MD20892, USA
    Surgery 150:1186-93. 2011
  2. ncbi Real-time FDG PET guidance during biopsies and radiofrequency ablation using multimodality fusion with electromagnetic navigation
    Aradhana M Venkatesan
    Center for Interventional Oncology, Radiology and Imaging Sciences, National Institutes of Health, 10 Center Dr, Bldg 10, Room 1C369, MSC 1182, Bethesda, MD 20892, USA
    Radiology 260:848-56. 2011
  3. ncbi Radiofrequency ablation of metastatic pheochromocytoma
    Aradhana M Venkatesan
    Center for Interventional Oncology, Department of Radiology and Imaging Sciences, National Institutes of Health Clinical Center, Bethesda, Maryland 20892, USA
    J Vasc Interv Radiol 20:1483-90. 2009
  4. ncbi Percutaneous ablation of adrenal tumors
    Aradhana M Venkatesan
    Center for Interventional Oncology, Department of Radiology and Imaging Sciences, National Institutes of Health Clinical Center, Bethesda, MD 20892, USA
    Tech Vasc Interv Radiol 13:89-99. 2010
  5. ncbi Percutaneous ablation in the kidney
    Aradhana M Venkatesan
    Department of Radiology and Imaging Sciences, NIH Clinical Center, 10 Center Dr, Bldg 10, Room 1C369, MSC 1182, Bethesda, MD 20892, USA
    Radiology 261:375-91. 2011
  6. ncbi Navigation systems for ablation
    Bradford J Wood
    Department of Radiology and Imaging Sciences, Clinical Center, National Institutes of Health, 9000 Rockville Pike, Building 10, Room 1C341 MSC 1182, Bethesda, MD 20892, USA
    J Vasc Interv Radiol 21:S257-63. 2010
  7. ncbi Radiofrequency ablation of renal tumors
    Michael J Stone
    National Institutes of Health Clinical Center, Diagnostic Radiology Department, Bethesda, MD 20892, USA
    Tech Vasc Interv Radiol 10:132-9. 2007
  8. ncbi Image-guided adrenal and renal biopsy
    Karun V Sharma
    Center for Interventional Oncology, Interventional Radiology, Radiology and Imaging Sciences, National Institutes of Health Clinical Center, Bethesda, MD 20892, USA
    Tech Vasc Interv Radiol 13:100-9. 2010
  9. ncbi Comparison of 6-18F-fluoro-L-DOPA, 18F-2-deoxy-D-glucose, CT, and MRI in patients with pancreatic neuroendocrine neoplasms with von Hippel-Lindau disease
    Mio Kitano
    Endocrine Oncology Section, Surgery Branch, National Cancer Institute, National Institutes of Health, CRC, 10 Center Drive, Bethesda, MD 20892, USA
    Surgery 150:1122-8. 2011
  10. ncbi Use of patient-specific MRI-based prostate mold for validation of multiparametric MRI in localization of prostate cancer
    Hari Trivedi
    Center for Interventional Oncology, Radiology and Imaging Sciences, Clinical Center, Molecular Imaging Program, Urologic Oncology Branch, Laboratory of Pathology, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892 1088, USA
    Urology 79:233-9. 2012

Collaborators

Detail Information

Publications10

  1. ncbi Comparison of clinical and imaging features in succinate dehydrogenase-positive versus sporadic paragangliomas
    Aradhana M Venkatesan
    Center for Interventional Oncology, Radiology and Imaging Sciences, National Institutes of Health, Bethesda, MD20892, USA
    Surgery 150:1186-93. 2011
    ..Limited data exist concerning the clinical and imaging features that distinguish sporadic from familial paragangliomas (PGLs)...
  2. ncbi Real-time FDG PET guidance during biopsies and radiofrequency ablation using multimodality fusion with electromagnetic navigation
    Aradhana M Venkatesan
    Center for Interventional Oncology, Radiology and Imaging Sciences, National Institutes of Health, 10 Center Dr, Bldg 10, Room 1C369, MSC 1182, Bethesda, MD 20892, USA
    Radiology 260:848-56. 2011
    ....
  3. ncbi Radiofrequency ablation of metastatic pheochromocytoma
    Aradhana M Venkatesan
    Center for Interventional Oncology, Department of Radiology and Imaging Sciences, National Institutes of Health Clinical Center, Bethesda, Maryland 20892, USA
    J Vasc Interv Radiol 20:1483-90. 2009
    ..3 months; range, 2.5-28 months). In conclusion, RF ablation may be safely performed for metastatic pheochromocytoma given careful attention to peri-procedural management...
  4. ncbi Percutaneous ablation of adrenal tumors
    Aradhana M Venkatesan
    Center for Interventional Oncology, Department of Radiology and Imaging Sciences, National Institutes of Health Clinical Center, Bethesda, MD 20892, USA
    Tech Vasc Interv Radiol 13:89-99. 2010
    ..Clinical and technical considerations unique to ablation in the adrenal gland are presented, including approaches commonly used in our practices, and risks and potential complications are discussed...
  5. ncbi Percutaneous ablation in the kidney
    Aradhana M Venkatesan
    Department of Radiology and Imaging Sciences, NIH Clinical Center, 10 Center Dr, Bldg 10, Room 1C369, MSC 1182, Bethesda, MD 20892, USA
    Radiology 261:375-91. 2011
    ..Clinical and technical considerations unique to ablation in the kidney are presented, and potential complications are discussed...
  6. ncbi Navigation systems for ablation
    Bradford J Wood
    Department of Radiology and Imaging Sciences, Clinical Center, National Institutes of Health, 9000 Rockville Pike, Building 10, Room 1C341 MSC 1182, Bethesda, MD 20892, USA
    J Vasc Interv Radiol 21:S257-63. 2010
    ..In this report, existing systems and techniques are reviewed and specific clinical applications for ablation are discussed to better define how these novel technologies address specific clinical needs and fit into clinical practice...
  7. ncbi Radiofrequency ablation of renal tumors
    Michael J Stone
    National Institutes of Health Clinical Center, Diagnostic Radiology Department, Bethesda, MD 20892, USA
    Tech Vasc Interv Radiol 10:132-9. 2007
    ..Clinical and technical considerations, risks, and complications pertaining to RFA of renal tumors are reviewed here, including approaches commonly used in our practice...
  8. ncbi Image-guided adrenal and renal biopsy
    Karun V Sharma
    Center for Interventional Oncology, Interventional Radiology, Radiology and Imaging Sciences, National Institutes of Health Clinical Center, Bethesda, MD 20892, USA
    Tech Vasc Interv Radiol 13:100-9. 2010
    ....
  9. ncbi Comparison of 6-18F-fluoro-L-DOPA, 18F-2-deoxy-D-glucose, CT, and MRI in patients with pancreatic neuroendocrine neoplasms with von Hippel-Lindau disease
    Mio Kitano
    Endocrine Oncology Section, Surgery Branch, National Cancer Institute, National Institutes of Health, CRC, 10 Center Drive, Bethesda, MD 20892, USA
    Surgery 150:1122-8. 2011
    ..The aim of our study was to determine the accuracy of (18)F-DOPA and (18)F-FDG to detect PNETs in patients with von Hippel-Lindau disease (vHL)...
  10. ncbi Use of patient-specific MRI-based prostate mold for validation of multiparametric MRI in localization of prostate cancer
    Hari Trivedi
    Center for Interventional Oncology, Radiology and Imaging Sciences, Clinical Center, Molecular Imaging Program, Urologic Oncology Branch, Laboratory of Pathology, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892 1088, USA
    Urology 79:233-9. 2012
    ..A significant difficulty to date has been accurate correlation between the magnetic resonance images and histopathologic specimens...